XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Changes in Equity
$ in Thousands
USD ($)
shares
Total equity attributable to Company shareholders
USD ($)
Capital stock
USD ($)
shares
Contributed surplus
USD ($)
Accumulated other comprehensive (loss), Total
USD ($)
Cumulative translation adjustment account
USD ($)
Reserve for cash flow hedges
USD ($)
Deficit
USD ($)
Non-controlling interest
USD ($)
Beginning balance, equity (in shares) at Dec. 31, 2018 | shares     58,650,310            
Beginning balance, equity at Dec. 31, 2018 $ 261,428 $ 249,847 $ 350,267 $ 17,074 $ (21,680) $ (24,170) $ 2,490 $ (95,814) $ 11,581
Transactions with owners                  
Exercise of stock options (Note 18) (in shares) | shares 359,375   359,375            
Exercise of stock options (Note 18) $ 3,278 3,278 $ 3,278            
Change in excess tax benefit on exercised share-based awards (Note 5) 0 0 38 (38)          
Change in excess tax benefit on outstanding share-based awards (Note 5) 21 21   21          
Share-based compensation (Note 18) 645 645   701       (56) [1]  
Share-based compensation expense credited to capital on options exercised (Note 18) 0 0 $ 976 (976)          
Dividends on common shares (Note 18) (33,834) (33,834)           (33,834)  
Increase (decrease) in transactions with owners (in shares) | shares     359,375            
Increase (decrease) in equity excluding comprehensive income (29,890) (29,890) $ 4,292 (292)       (33,890)  
Net earnings 41,224 41,216           41,216 8
Other comprehensive income (loss)                  
Change in fair value of interest rate swap agreements designated as cash flow hedges (Note 24) [2] (3,057) [3] (3,057)     (3,057)   (3,057)    
Reclassification adjustments for amounts recognized in earnings related to interest rate swap agreements (Note 24) (503) (503)     (503)   (503)    
Remeasurement of defined benefit liability (Note 20) [5] 589 [4] 589           589  
Change in cumulative translation adjustments (7,798) [6] (7,697)     (7,697) (7,697)     (101)
Net gain (loss) arising from hedge of a net investment in foreign operations (Note 24) [8] 10,235 [7] 10,235     10,235 10,235      
Other comprehensive (loss) income (534) (433)     (1,022) 2,538 (3,560) 589 (101)
Comprehensive (loss) income for the year 40,690 40,783     (1,022) 2,538 (3,560) 41,805 (93)
Ending balance, equity (in shares) at Dec. 31, 2019 | shares     59,009,685            
Ending balance, equity at Dec. 31, 2019 $ 272,228 260,740 $ 354,559 16,782 (22,702) (21,632) (1,070) (87,899) 11,488
Transactions with owners                  
Exercise of stock options (Note 18) (in shares) | shares 17,362   17,362            
Exercise of stock options (Note 18) $ 271 271 $ 271            
Change in excess tax benefit on exercised share-based awards (Note 5)       0          
Change in excess tax benefit on outstanding share-based awards (Note 5) 5,306 5,306   5,306          
Share-based compensation (Note 18) 738 738   738          
Share-based compensation expense credited to capital on options exercised (Note 18) 0 0 $ 50 (50)          
Dividends on common shares (Note 18) (35,405) (35,405)           (35,405)  
Increase (decrease) in transactions with owners (in shares) | shares     17,362            
Increase (decrease) in equity excluding comprehensive income (29,090) (29,090) $ 321 5,994       (35,405)  
Net earnings 73,455 72,670           72,670 785
Other comprehensive income (loss)                  
Change in fair value of interest rate swap agreements designated as cash flow hedges (Note 24) [9] (2,027) [3] (2,027)     (2,027)   (2,027)    
Reclassification adjustments for amounts recognized in earnings related to interest rate swap agreements (Note 24) 0                
Remeasurement of defined benefit liability (Note 20) [10] (480) [4] (480)           (480)  
Change in cumulative translation adjustments [11] (3,028) [6] (2,881)     (2,881) (2,881)     (147)
Net gain (loss) arising from hedge of a net investment in foreign operations (Note 24) [12] 5,724 [7] 5,724     5,724 5,724      
Other comprehensive (loss) income 189 336     816 2,843 (2,027) (480) (147)
Comprehensive (loss) income for the year 73,644 73,006     816 2,843 (2,027) 72,190 638
Dividend paid to non-controlling interest in GPCP Inc. $ (100)               (100)
Ending balance, equity (in shares) at Dec. 31, 2020 | shares 59,027,047   59,027,047            
Ending balance, equity at Dec. 31, 2020 $ 316,682 304,656 $ 354,880 22,776 (21,886) (18,789) (3,097) (51,114) 12,026
Transactions with owners                  
Exercise of stock options (Note 18) (in shares) | shares 257,900   257,900            
Exercise of stock options (Note 18) $ 2,664 2,664 $ 2,664            
Change in excess tax benefit on exercised share-based awards (Note 5) 0 0 672 (672)          
Change in excess tax benefit on outstanding share-based awards (Note 5) 824 824   824          
Share-based compensation (Note 18) 879 879   879          
Share-based compensation expense credited to capital on options exercised (Note 18) 0 0 $ 737 (737)          
Dividends on common shares (Note 18) (38,751) (38,751)           (38,751)  
Increase (decrease) in transactions with owners (in shares) | shares     257,900            
Increase (decrease) in equity excluding comprehensive income (34,384) (34,384) $ 4,073 294       (38,751)  
Net earnings 70,005 67,813           67,813 2,192
Other comprehensive income (loss)                  
Change in fair value of interest rate swap agreements designated as cash flow hedges (Note 24) [13] 1,806 [3] 1,806     1,806   1,806    
Reclassification adjustments for amounts recognized in earnings related to interest rate swap agreements (Note 24) 0                
Remeasurement of defined benefit liability (Note 20) [14] 3,939 [4] 3,939           3,939  
Change in cumulative translation adjustments 5,212 [6] 5,343     5,343 5,343     (131)
Net gain (loss) arising from hedge of a net investment in foreign operations (Note 24) [15] (11,012) [7] (11,012)     (11,012) (11,012)      
Other comprehensive (loss) income (55) 76     (3,863) (5,669) 1,806 3,939 (131)
Comprehensive (loss) income for the year $ 69,950 67,889     (3,863) (5,669) 1,806 71,752 2,061
Ending balance, equity (in shares) at Dec. 31, 2021 | shares 59,284,947   59,284,947            
Ending balance, equity at Dec. 31, 2021 $ 352,248 $ 338,161 $ 358,953 $ 23,070 $ (25,749) $ (24,458) $ (1,291) $ (18,113) $ 14,087
[1] Presented net of income tax benefit of $3.
[2] Presented net of deferred income tax benefit of $359
[3] Presented net of deferred income tax expense (benefit) of $577 in 2021, ($658) in 2020 and ($359) in 2019.
[4] Presented net of deferred income tax expense (benefit) of $1,366 in 2021, ($216) in 2020, and $173 in 2019.
[5] Presented net of deferred income tax expense of $173.
[6] Presented net of deferred income tax expense of $281 in 2020 (nil in 2021 and 2019).
[7] Presented net of deferred income tax expense of $1,589 in 2021, $764 in 2020 and $45 in 2019.
[8] Presented net of deferred income tax expense of $45.
[9] Presented net of deferred income tax benefit of $658.
[10] Presented net of deferred income tax benefit of $216.
[11] Presented net of deferred income tax expense of $281.
[12] Presented net of deferred income tax expense of $764.
[13] Presented net of deferred income tax expense of $577.
[14] Presented net of deferred income tax expense of $1,366.
[15] Presented net of deferred income tax expense of $1,589.